Cytokinetics makes a commitment to the climate and carries out its carbon assessment

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, they are developing small molecule drug candidates specifically engineered to impact muscle function and contractility.

33ceefa8 4b0f 4962 a63a 6a78f7c57073 sporlab XiZ7pRvCzro unsplash

1998

Date of creation

424

Number of employees

2021

Year analyzed